- Generic name
- Letrozole
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Manufactured by
- Chemist Laboratories Ltd.
Letrozole Tablet
About Letrozole 2.5 mg Tablet
Letrozole 2.5 mg is a tablet product of Chemist Laboratories Ltd. that contains Letrozole. Letrozole is used for the first-line treatment of advanced or metastatic breast cancer in post-menopausal women when the tumour is hormone receptor positive or its receptor status is unknown.
There are 7 brands of Letrozole listed in Bangladesh. The lowest listed price is Ovazol 2.5 mg Tablet at ৳ 40.00 per unit.
What is Letrozole 2.5 mg Tablet?
Letrozole 2.5 mg tablet is a medicine made by Chemist Laboratories Ltd. Treatment is supervised by a cancer specialist, who decides how long it should continue and whether it should be stopped if the tumour stops responding. Letrozole is an aromatase inhibitor: it reduces the amount of oestrogen the body makes, which can slow the growth of cancers that depend on oestrogen. Ask your doctor or pharmacist if you are unsure about it.
Uses of Letrozole
Letrozole is used for the first-line treatment of advanced or metastatic breast cancer in post-menopausal women when the tumour is hormone receptor positive or its receptor status is unknown. It is a hormonal chemotherapy that reduces estrogen levels, which can slow the growth of certain breast cancers. Your doctor will decide if it is suitable for you.
How to use Letrozole
Your doctor decides the dose, how often you take it and how long the course lasts, and you should follow those instructions exactly. Swallow the tablet with water. Letrozole is taken by mouth. If you miss a dose, ask your doctor or pharmacist for advice. The doctor decides the dose and how long the course should continue, and treatment usually carries on as long as the tumour is responding.
Side effects of Letrozole
Many side effects of Letrozole are mild to moderate. Some people may experience coughing, constipation, vomiting, diarrhoea, rash, or swelling of the ankles. Contact your doctor if you notice anything unusual after taking it. Tell your doctor about any side effect that troubles you.
Safety and precautions
Before starting it, tell your doctor about any liver or kidney problems, all other medicines you take, and any allergies. It is also not for people with severe liver problems or allergy to Letrozole or similar medicines. Do not use it during pregnancy or breastfeeding. Ask your doctor first if any of these apply to you.
Frequently asked questions
Why is Letrozole prescribed?
Letrozole is used for the first-line treatment of advanced or metastatic breast cancer in post-menopausal women when the tumour is hormone receptor positive or its receptor status is unknown. It is a hormonal chemotherapy that reduces estrogen levels, which can slow the growth of certain breast cancers.
How is Letrozole used?
Your doctor decides the dose, how often you take it and how long the course lasts, and you should follow those instructions exactly. Swallow the tablet with water.
What should I watch for while using Letrozole?
Many side effects of Letrozole are mild to moderate. Some people may experience coughing, constipation, vomiting, diarrhoea, rash, or swelling of the ankles.
Who should be careful with Letrozole?
Before starting it, tell your doctor about any liver or kidney problems, all other medicines you take, and any allergies. It is also not for people with severe liver problems or allergy to Letrozole or similar medicines.
Indications
Pharmacology
In healthy postmenopausal women, single doses of 0.1, 0.5 and 2.5mg letrozole suppress serum oestrone and oestradiol by 75-78% and 78% from baseline respectively. Maximum suppression is achieved in 48-78 hours. In post-menopausal patients, with advanced breast cancer, daily doses of 0.1 to 5mg suppress plasma concentration of oestradiol, oestrone, and oestrone sulphate by 78-95% from baseline in all patients treated. Letrozole had no effect on plasma androgen concentrations (androstenedione and testosterone) among healthy postmenopausal women after single doses of 0.1, 0.5 and 2.5mg indicating that the blockade of estrogen biosynthesis does not lead to accumulation of androgenic precursors. Impairment of adrenal steroidogenesis has not been observed.
Pharmacokinetics: Letrozole is rapidly and completely absorbed from the gastrointestinal tract (absolute bioavailability 99.9%). Food slightly decreases the rate of absorption, but the extent of absorption remains unchanged. The minor effect of the absorption rate is not considered to be of clinical relevance and therefore letrozole may be taken after, with or before food. Plasma protein binding of letrozole is approximately 60%, mainly to albumin (55%). The concentration of letrozole in erythrocytes is about 80% of that in plasma. Metabolic clearance to a pharmacologically inactive carbinol metabolite is the major elimination pathway of letrozole but is relatively slow when compared to hepatic blood flow. The cytochrome P450 isoenzymes 3A4 and 2A6 were found to be capable of converting letrozole to this metabolite in vitro but their individual contributions to letrozole metabolism in vivo have not been established. The apparent terminal elimination half-life in plasma is about 2 days. After daily administration of 2.5mg of letrozole, steady-state levels are reached within 2 to 6 weeks.
Dosage & Administration
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Letrozole
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.